ArticleBMC cardiovascular disorders2026
The predictive value of TC/HDL ratio in patients with acute myocardial infarction undergoing PCI.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundTotal cholesterol to high-density lipoprotein (TC/HDL) ratio has not been fully established following acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI) in clinical practice. Therefore, we sought to evaluate the relationship between TC/HDL ratio and major adverse cardiovascular events (MACEs) in AMI undergoing PCI patients.
methods398 patients who subjected to AMI undergoing PCI were included in this study. Blood samples were obtained and analyzed before patients underwent PCI. Patients were followed up until 6 months after discharge, and MACEs were recorded.
resultsThe incidence of MACEs was 25.4% (101 out of 398 patients). The TC/HDL ratio was significantly higher in the MACEs group compared to the non-MACEs group. In multivariate cox regression analysis, TC/HDL ratio level [adjusted hazard ratio (HR): 2.521, 95% confidence interval (CI): 1.902–3.343; p < 0.001] was identified as a significant independent positive predictor of MACEs. In receiver operating characteristic curve, the area under the curve value for TC/HDL ratio in predicting MACEs was 0.748. Kaplan-Meier survival analysis revealed that patients in the low TC/HDL group had significantly higher event-free survival (EFS) rate compared to those in the high TC/HDL group (p < 0.001).
conclusionsTC/HDL ratio levels demonstrate moderate predictive value for MACEs in patients with AMI undergoing PCI, which providing additional information to the commonly used clinical markers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.